NGM Stock: NGM Biopharmaceuticals, Inc. Stock Price, Analysis & Insights

Get live NGM stock price $1.54, comprehensive NGM Biopharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time NGM stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

1.54

1.28%Today

NGM • NGM Biopharmaceuticals, Inc. • NASDAQ Global Select • Healthcare

Market Cap

128.53M

Volume

2.21M

52W High

4.69

52W Low

0.60

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

NGM Biopharmaceuticals, Inc. is a biotechnology company focused on discovering and developing innovative therapies for liver and metabolic ailments, retinal conditions, and various forms of cancer. The company's advanced product candidates include Al...

Contact Information

Website: https://www.ngmbio.com
Address: 333 Oyster Point Boulevard
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Higher growth potential with elevated volatility (Beta: 1.26)

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for NGM Biopharmaceuticals, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for NGM Biopharmaceuticals, Inc.
⚠Investors should consider how NGM Biopharmaceuticals, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

128.53M

P/E Ratio (TTM)

-0.89

Beta

1.26

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare NGM with peer companies:

aTyr Pharma, Inc. (ATYR)

Price: $0.46
Market cap: 45.38M

Decibel Therapeutics, Inc. (DBTX)

Price: $4.91
Market cap: 123.37M

Graybug Vision, Inc. (GRAY)

Price: $5.50
Market cap: 120.98M

Kinnate Biopharma Inc. (KNTE)

Price: $2.65
Market cap: 124.99M

Pardes Biosciences, Inc. (PRDS)

Price: $2.18
Market cap: 135.19M

Paratek Pharmaceuticals, Inc. (PRTK)

Price: $2.23
Market cap: 127.83M

RVL Pharmaceuticals plc (RVLP)

Price: $0.03
Market cap: 3.14M

Selecta Biosciences, Inc. (SELB)

Price: $0.88
Market cap: 135.20M

Sesen Bio, Inc. (SESN)

Price: $0.63
Market cap: 127.96M

Tourmaline Bio, Inc. (TRML)

Price: $47.98
Market cap: 1.23B

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.